1. Nanocurcumin: A novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function. Issue 7 (25th February 2019) Authors: Hajialilo, Mehrzad; Dolati, Sanam; Abdolmohammadi‐Vahid, Samaneh; Ahmadi, Majid; Kamrani, Amin; Eghbal‐Fard, Shadi; Ghassembaglou, Arezou; Valizadeh, Amir; Shenas, Mohammad Hossein Musavi; Aghebati‐Maleki, Leili; Kafil, Hossein Samadi; Mehdizadeh, Amir; Yousefi, Mehdi Journal: Journal of cellular biochemistry Issue: Volume 120:Issue 7(2019) Page Start: 12027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double‐blind, placebo‐controlled clinical trial. Issue 1 (9th May 2019) Authors: Ahmadi, Majid; Hajialilo, Mehrzad; Dolati, Sanam; Eghbal‐Fard, Shadi; Heydarlou, Hanieh; Ghaebi, Mahnaz; Ghassembaglou, Arezou; Aghebati‐Maleki, Leili; Samadi Kafil, Hossein; Kamrani, Amin; Rahnama, Badrossadat; Rikhtegar, Reza; Yousefi, Mehdi Journal: Journal of cellular biochemistry Issue: Volume 121:Issue 1(2020) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗